Manish Bharti
Manish Bharti is Sales Leader at UiPath. He brings in 21 years of global techno- businesses experiences with his current focus on working with large enterprises on their transformation journey involving RPA, Cognitive & AI.
In his current role as a Revenue Officer, he is responsible for building top line revenues and drive customer acquisitions and delight. Manish is an alumnus of IIM-B & HBS
Paulo Refinetti
Arvind Kasturirangan
Balaji Hariharan
Rajesh Krishnaswamy
Vishal Dogra
Mallory Embree
Mallory’s entire career has focused on researching and developing new methodologies to study both natural and synthetic microbial communities. Her area of expertise centers around the integration of bioinformatics with multiple omics datasets, physiological measurements, and metabolic modeling to examine microbial communities from a species-centric perspective. She has studied microbial communities from a diverse range of environments beyond livestock, including liver-disease mouse models, human skin microbiomes, brewery wastewater digesters, slow-growing methanogenic alkane-degrading enrichments, and low-biomass deep subsurface sediments from the ocean gyres.
Together with her co-founder, Mike Seely, Mallory founded Ascus Biosciences in 2015 to discover, develop, and commercialize first-in-class endomicrobial products for the animal health & nutrition industries. Outside of her passion for microbial communities and microbial product development, Mallory spends a lot of her free time working on airplanes, hot-air balloons and doing yoga. Mallory received her Ph.D. in Bioengineering from the University of California, San Diego.
About Ascus
Ascus Biosciences, based in San Diego, CA, is focused on discovering, developing, and commercializing first-in-class endomicrobial products for the animal health and nutrition industries. Founded in 2015, Ascus is pioneering the emerging science of endomicrobial ecology to illuminate microbial communities within animals, and the role they play in overall health and performance. Ascus has a broad pipeline of all-natural, endomicrobial products in development across livestock and companion animals. Galaxis is their lead product and could launch as early as 2018 in the dairy market.